Hyper-lipoprotein(a) levels >300 mg/l were strongly associated with severe coronary stenosis (OR 3.25; 95% CI 1.90-5.54), which in turn increased the risk of myocardial infarction.
Observational (n=1,062)
No
Does high lipoprotein(a) level increase the risk of coronary atherosclerosis and myocardial infarction in geriatric patients?
High Lp(a) levels independently promote both coronary atherosclerosis and myocardial infarction, supporting its prothrombotic and proinflammatory role in coronary events.
Odds Ratio: 3.25 (95% CI 1.9–5.54)
OBJECTIVE: To investigate whether hyper-lipoproteinaemia(a) (Lp(a)) promotes coronary atherosclerosis, acute thrombosis resulting in myocardial infarction (MI), or both. DESIGN: Retrospective chart review. SETTING: A community-based general geriatric hospital. PATIENTS: 1062 consecutive autopsy cases (609 men, 453 women). The mean age at the time of death was 80 years. MAIN OUTCOME MEASURES: A semiquantitative evaluation of the coronary stenosis on cut sections and pathological definition of MI. Lp(a) levels of fresh serum taken antemortem, measured by a latex-enhanced turbidimetric immunoassay. RESULTS: The prevalence of severe coronary stenosis and pathological MI increased linearly with increasing Lp(a) levels with no apparent threshold. The odds ratios (95% CI) of hyper-Lp(a) (2.99 (1.70 to 5.28) for 200-299 mg/l and 3.25 (1.90 to 5.54) for >300 mg/l) for severe coronary stenosis were larger than those of hypertension (2.61 (1.88 to 3.63)), diabetes mellitus (2.09 (1.41 to 3.11)) and hypercholesterolaemia (2.05 (1.31 to 3.21)). The severe coronary sclerosis was much stronger risk of MI (6.28 (4.33 to 9.11)) than hyper-Lp(a), hypertension and diabetes mellitus. A path analysis showed that the Lp(a) levels affected both coronary sclerosis and MI, with path coefficients of 0.15 and 0.07 (direct effect), respectively. In cases with severe coronary sclerosis Lp(a) affected only MI (0.15). CONCLUSIONS: Lp(a) levels have distinct effects on coronary sclerosis and MI, with about half of the overall effect on MI being via coronary sclerosis. This result supports the prothrombotic and a probable proinflammatory role of Lp(a) in coronary events.
Sawabe et al. (2009) conducted an observational in Coronary atherosclerosis and myocardial infarction (n=1,062). Hyper-lipoproteinaemia(a) (Lp(a)) vs. Lower Lp(a) levels was evaluated on Severe coronary stenosis (OR 3.25, 95% CI 1.90 to 5.54). Hyper-lipoprotein(a) levels >300 mg/l were strongly associated with severe coronary stenosis (OR 3.25; 95% CI 1.90-5.54), which in turn increased the risk of myocardial infarction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: